1 Product identity
Ingredient risk
1 ingredient to use with caution

Promensil Menopause Double Strength

BrandReal Health Laboratories→Botanical with Nutrients Tablet or Pill 11 ingredients 1 caution DSLD #214069
Net contents: 30 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2020-03-24
2 Ingredients (11)
IngredientGroupSafety
CalciumCalciumConditionally Safe
standardized Red Clover extractRed CloverConditionally Safe
IsoflavonesIsoflavones—
Calcium PhosphateCalciumConditionally Safe
Microcrystalline CelluloseCellulose—
Coating SolutionCoating—
SilicaSiliconGenerally Safe
Croscarmellose SodiumCroscarmellose Sodium—
Magnesium StearateMagnesium stearateUse with Caution
Mixed TocopherolsVitamin EConditionally Safe
Carnauba WaxCarnauba wax—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Red Clover — Conditionally Safe
⚠ Estrogenic (isoflavones)
⚠ May increase bleeding risk
Silicon — Generally Safe
⚠ Very low toxicity
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Vitamin E — Conditionally Safe
⚠ Increased bleeding risk
⚠ All-cause mortality at >400 IU/day
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID214069
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2020-03-24
6 More from Real Health Laboratories
View Real Health Laboratories Safety Scorecard → 1 products
7 Cite this page
Vancouver
Pkhakadze G. Promensil Menopause Double Strength — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 17]. Available from: https://supplement.ge/products/dsld-214069/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network